Glaucoma is a complex condition of the eye. It is an ophthalmic neurodegenerative condition
and is characterised by raised intraocular pressure. When left untreated, patients may …

Introduction: Glaucoma is the second leading cause of blindness in the world and current
pharmacotherapies for glaucoma have remained relatively unchanged (with the exception of …

There have been numerous recent advances in the management of glaucoma, not least the
development of new drugs to help manage raised intraocular pressure. In addition, the …

Accepted for publication 23.02. 2012. Glaucoma refers to a group of eye conditions that lead
to damage to the optic nerve, the nerve that carries visual information from the eye to the …

Glaucoma is the first cause of irreversible blindness worldwide. Its prevalence in our country
is 2%; half of patients remain undiagnosed. Certain drugs can trigger and/or exacerbate …

Introduction: Glaucoma is a disease of the eye in which the optic nerve and retinal ganglion
cells (RGCs) are injured, leading to the loss of the peripheral visual field and eventually to …

The management of glaucoma has been considerably improved in the last three decades.
On the basis of deeper understanding about the cellular, molecular, and genetic levels …

Although challenges in medical treatment of glaucoma exist, particularly in patient
adherence, medical therapy remains the first line treatment for almost all glaucoma patients …

Glaucoma is a multifactorial optic neuropathy in which there is a characteristic acquired loss
of retinal ganglion cells, at levels beyond normal age-related baseline loss, and …

Glaucoma is a group of diseases involving the optic nerve and associated structures, which
is characterized by progressive visual field loss and typical changes of the optic nerve head …